Q4 2019 MEI Pharma Inc Earnings Call Transcript
Good afternoon and welcome to the MEI Pharma 2019 Fiscal Year-End Conference Call. Please be advised that this conference call is being recorded at the company's request. (Operator Instructions) At this time, I would like to turn the call over to Mr. David Walsey, MEI's Vice President, Investor Relations and Corporate Communications. Please proceed.
Thank you. Good afternoon, everyone, and thank you for joining us. After the market closed today, we filed our Form 10-K for the fiscal year ended June 30, 2019, with the Securities and Exchange Commission and issued our final results and corporate highlights press release, both of which are available in the Investors section of our website at www.meipharma.com.
On our call today, we will provide a summary of financials from the fiscal year ended June 30, 2019, and then review progress in our programs and business over the last year. We will then open the call up to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |